Ryan Halsted
Stock Analyst at RBC Capital
(0.96)
# 5,150
Out of 5,182 analysts
14
Total ratings
33.33%
Success rate
-9.21%
Average return
Main Sectors:
Stocks Rated by Ryan Halsted
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Outperform | $522 → $484 | $413.59 | +17.02% | 2 | Apr 24, 2026 | |
| HCSG Healthcare Services Group | Maintains: Sector Perform | $22 → $24 | $21.33 | +12.52% | 2 | Apr 23, 2026 | |
| DOCS Doximity | Reiterates: Outperform | $44 | $24.20 | +81.82% | 1 | Mar 9, 2026 | |
| IQV IQVIA Holdings | Initiates: Outperform | $221 | $156.66 | +41.07% | 1 | Mar 3, 2026 | |
| MDLN Medline | Maintains: Outperform | $47 → $53 | $43.40 | +22.12% | 2 | Feb 26, 2026 | |
| EVH Evolent Health | Maintains: Sector Perform | $5 → $3 | $3.79 | -20.84% | 1 | Feb 25, 2026 | |
| PRVA Privia Health Group | Reinstates: Outperform | $31 | $24.69 | +25.56% | 1 | Jan 9, 2026 | |
| TBRG TruBridge | Reinstates: Sector Perform | $23 | $25.73 | -10.61% | 1 | Jan 9, 2026 | |
| ENSG The Ensign Group | Downgrades: Underperform | n/a | $186.40 | - | 3 | Apr 28, 2017 |
Medpace Holdings
Apr 24, 2026
Maintains: Outperform
Price Target: $522 → $484
Current: $413.59
Upside: +17.02%
Healthcare Services Group
Apr 23, 2026
Maintains: Sector Perform
Price Target: $22 → $24
Current: $21.33
Upside: +12.52%
Doximity
Mar 9, 2026
Reiterates: Outperform
Price Target: $44
Current: $24.20
Upside: +81.82%
IQVIA Holdings
Mar 3, 2026
Initiates: Outperform
Price Target: $221
Current: $156.66
Upside: +41.07%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $47 → $53
Current: $43.40
Upside: +22.12%
Evolent Health
Feb 25, 2026
Maintains: Sector Perform
Price Target: $5 → $3
Current: $3.79
Upside: -20.84%
Privia Health Group
Jan 9, 2026
Reinstates: Outperform
Price Target: $31
Current: $24.69
Upside: +25.56%
TruBridge
Jan 9, 2026
Reinstates: Sector Perform
Price Target: $23
Current: $25.73
Upside: -10.61%
The Ensign Group
Apr 28, 2017
Downgrades: Underperform
Price Target: n/a
Current: $186.40
Upside: -